Celularity (CELU) News Today $1.75 -0.01 (-0.57%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.76 +0.01 (+0.57%) As of 06/13/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELU Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Celularity (NASDAQ:CELU) Shares Down 10.4% - Here's WhyJune 12 at 2:31 AM | americanbankingnews.com# Celularity terminates CFO, appoints interim replacementJune 11 at 8:08 PM | investing.comCelularity Inc. Announces Termination of CFO David Beers, Appoints Joseph DosSantos as Interim CFOJune 11 at 8:08 PM | nasdaq.comCelularity stock falls after CFO David Beers terminatedJune 10, 2025 | au.investing.comCelularity Terminates CFO David BeersJune 10, 2025 | marketwatch.comCelularity Announces Chief Financial Officer TransitionJune 10, 2025 | globenewswire.comCelularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane TechnologyJune 2, 2025 | globenewswire.comCELUW Celularity Inc. WT EXP 071626June 1, 2025 | seekingalpha.comCelularity Inc.: Celularity Receives Nasdaq Notice Regarding Form 10-QMay 31, 2025 | finanznachrichten.deCelularity Receives Nasdaq Notice Regarding Form 10-QMay 30, 2025 | globenewswire.comCelularity (NASDAQ:CELU) Stock Rating Lowered by Wall Street ZenWall Street Zen cut Celularity from a "hold" rating to a "sell" rating in a research report on Thursday.May 24, 2025 | marketbeat.comCelularity (NASDAQ:CELU) Trading 7.4% Higher - Here's WhyCelularity (NASDAQ:CELU) Stock Price Up 7.4% - Here's WhyMay 23, 2025 | marketbeat.comCelularity extiende vencimiento de deuda y emite acciones a YA II PNMay 22, 2025 | es.investing.comCelularity extends debt maturity, issues stock to YA II PNMay 22, 2025 | uk.investing.comCelularity Extends Note Maturity with YA II PNMay 20, 2025 | tipranks.comCelularity Inc.: Celularity Announces Full Year 2024 Operating and Financial ResultsMay 9, 2025 | finanznachrichten.deCelularity Inc. Reports Strong Financial Growth and Increased Revenue for Year Ended December 31, 2024May 9, 2025 | quiverquant.comCelularity Announces Full Year 2024 Operating and Financial ResultsMay 9, 2025 | globenewswire.comCelularity receives notice regarding non-payment of Nasdaq feesApril 26, 2025 | markets.businessinsider.comCelularity pays $70,000 fee to Nasdaq following receipt of noticeApril 26, 2025 | msn.comCelularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq FeesApril 25, 2025 | globenewswire.comCelularity welcomes CMS action on Medicare LCD for skin substitutes productsApril 15, 2025 | markets.businessinsider.comCelularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes ProductsApril 14, 2025 | globenewswire.comCelularity announces publication highlighting potential of CYNK-001April 9, 2025 | markets.businessinsider.comCelularity extiende vencimiento de deuda y emite acciones a inversionistaMarch 23, 2025 | es.investing.comCelularity extends debt maturity, issues stock to investorMarch 23, 2025 | uk.investing.comCelularity receives FDA TRG recommendation letters for Natalin, AcelagraftFebruary 25, 2025 | msn.comCelularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care ProductsFebruary 25, 2025 | markets.businessinsider.comCelularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care ProductsFebruary 25, 2025 | globenewswire.comCelularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy CompanyFebruary 24, 2025 | globenewswire.comMASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDsJanuary 27, 2025 | markets.businessinsider.comCelularity amends warrant terms, secures $2.46 million fundingJanuary 27, 2025 | msn.comCelularity Faces Challenges as Agreement ExpiresJanuary 24, 2025 | tipranks.comCelularity announces resolution of Nasdaq listing compliance matterDecember 11, 2024 | markets.businessinsider.comCelularity Inc. Announces Resolution of Nasdaq Listing Compliance MatterDecember 10, 2024 | globenewswire.comCelularity reports Q3 EPS (73c) vs. ($4.98) last yearDecember 6, 2024 | msn.comCelularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023December 6, 2024 | markets.businessinsider.comCelularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023December 6, 2024 | globenewswire.comCelularity Inc. (CELUW)November 28, 2024 | finance.yahoo.comCelularity receives Nasdaq listing non-compliance noticeNovember 28, 2024 | markets.businessinsider.comCelularity Inc. Announces Receipt of Nasdaq NotificationNovember 27, 2024 | globenewswire.comCelularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia PacificNovember 20, 2024 | markets.businessinsider.comCelularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia PacificNovember 20, 2024 | globenewswire.comCelularity Inc. Announces Resolution of Nasdaq Listing Compliance MatterNovember 18, 2024 | globenewswire.comCelularity Inc. (NASDAQ:CELU) Sees Significant Increase in Short InterestCelularity Inc. (NASDAQ:CELU - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 743,700 shares, an increase of 9.3% from the October 15th total of 680,500 shares. Based on an average daily volume of 876,800 shares, the short-interest ratio is currently 0.8 days. Approximately 6.9% of the shares of the company are short sold.November 17, 2024 | marketbeat.comCelularity (NASDAQ:CELU) Stock Quotes, Forecast and News SummaryNovember 8, 2024 | benzinga.comCelularity raises FY24 revenue view to $54M-$60M from $50M-$56MNovember 7, 2024 | markets.businessinsider.comCelularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 MillionNovember 7, 2024 | finance.yahoo.comCelularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings PanelOctober 23, 2024 | globenewswire.comCelularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an AppealOctober 18, 2024 | globenewswire.com Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Email Address CELU Media Mentions By Week CELU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELU News Sentiment▼0.370.88▲Average Medical News Sentiment CELU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELU Articles This Week▼71▲CELU Articles Average Week Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRUG News Today IPHA News Today CYBN News Today PRQR News Today LYEL News Today VYGR News Today NVCT News Today OGI News Today ELDN News Today PBYI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELU) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celularity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
